Regeneron files Form 13F: $700.4M holdings
REGENERON PHARMACEUTICALS, INC. filed a Form 13F reporting institutional holdings totaling $700,444,832.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
REGENERON PHARMACEUTICALS, INC. filed a Form 13F reporting institutional holdings totaling $700,444,832. The filing lists 4 information-table entries and was submitted as a 13F Holdings Report by the reporting manager. The report certifies the information is true and complete and is signed by Leonard Brooks, Senior Vice President, Treasurer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does REGN's Form 13F disclose?
Who filed the 13F for REGN and who signed it?
How many holdings entries are listed in the REGN 13F filing?
What is the total value reported on REGN's 13F summary page?
Does the 13F filing indicate any amendments or other included managers?
AI-generated analysis. How Rhea-AI works. Not financial advice.